UA61870C2 - Method for treating acne and pseudofolliculitis barbae, methods for producing compositions, composition for treating acne - Google Patents
Method for treating acne and pseudofolliculitis barbae, methods for producing compositions, composition for treating acne Download PDFInfo
- Publication number
- UA61870C2 UA61870C2 UA94005502A UA94005502A UA61870C2 UA 61870 C2 UA61870 C2 UA 61870C2 UA 94005502 A UA94005502 A UA 94005502A UA 94005502 A UA94005502 A UA 94005502A UA 61870 C2 UA61870 C2 UA 61870C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- acne
- composition
- difluoromethyl
- pharmacologically acceptable
- Prior art date
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 19
- 206010000496 acne Diseases 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 11
- 239000000203 mixture Substances 0.000 title claims description 10
- 208000001818 Pseudofolliculitis barbae Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 claims abstract description 11
- 102000052812 Ornithine decarboxylases Human genes 0.000 claims abstract description 7
- 108700005126 Ornithine decarboxylases Proteins 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 22
- VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical group NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 claims description 12
- 231100000252 nontoxic Toxicity 0.000 claims description 5
- 230000003000 nontoxic effect Effects 0.000 claims description 5
- 229940125532 enzyme inhibitor Drugs 0.000 claims 1
- 239000002532 enzyme inhibitor Substances 0.000 claims 1
- 238000012876 topography Methods 0.000 claims 1
- 230000002280 anti-androgenic effect Effects 0.000 description 4
- 239000000051 antiandrogen Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 150000004492 retinoid derivatives Chemical class 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- LZSOOHLAZHOTHJ-GUCLMQHLSA-N topterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](CCC)(O)[C@@]1(C)CC2 LZSOOHLAZHOTHJ-GUCLMQHLSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DFRQHISHXQPKMU-GUCLMQHLSA-N (8r,9s,10r,13s,14s,17r)-17-hydroxy-10,13-dimethyl-17-prop-2-enyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 DFRQHISHXQPKMU-GUCLMQHLSA-N 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- -1 benzoin peroxide Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- WDFKMLRRRCGAKS-UHFFFAOYSA-N chloroxine Chemical compound C1=CN=C2C(O)=C(Cl)C=C(Cl)C2=C1 WDFKMLRRRCGAKS-UHFFFAOYSA-N 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000404 nontoxic agent Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/785,032 US5328686A (en) | 1991-10-30 | 1991-10-30 | Treatment of acne or of pseudofolliculitis barbae |
| PCT/US1992/009128 WO1993008790A1 (en) | 1991-10-30 | 1992-10-28 | Treatment of acne or of pseudofolliculitis barbae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA61870C2 true UA61870C2 (en) | 2003-12-15 |
Family
ID=25134267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA94005502A UA61870C2 (en) | 1991-10-30 | 1992-10-28 | Method for treating acne and pseudofolliculitis barbae, methods for producing compositions, composition for treating acne |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5328686A (ru) |
| EP (1) | EP0610368B1 (ru) |
| JP (1) | JP3534751B2 (ru) |
| KR (1) | KR100264829B1 (ru) |
| AT (1) | ATE174785T1 (ru) |
| AU (1) | AU675918B2 (ru) |
| CA (1) | CA2121484C (ru) |
| DE (1) | DE69228000T2 (ru) |
| DK (1) | DK0610368T3 (ru) |
| ES (1) | ES2125276T3 (ru) |
| HU (1) | HU219949B1 (ru) |
| OA (1) | OA09920A (ru) |
| RU (1) | RU2130768C1 (ru) |
| UA (1) | UA61870C2 (ru) |
| WO (1) | WO1993008790A1 (ru) |
| ZA (1) | ZA928345B (ru) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5851537A (en) * | 1996-02-02 | 1998-12-22 | Cancer Technologies, Inc. | Topical application of α-DFMO for preventing skin cancer |
| US6121269A (en) * | 1999-02-22 | 2000-09-19 | Henry; James P. | Reduction of hair growth |
| US6235737B1 (en) | 2000-01-25 | 2001-05-22 | Peter Styczynski | Reduction of hair growth |
| US6299865B1 (en) | 2000-05-02 | 2001-10-09 | Peter Styczynski | Reduction of hair growth |
| US7439271B2 (en) | 2001-06-27 | 2008-10-21 | The Gillette Company | Reduction of hair growth |
| US7261878B2 (en) * | 2001-08-10 | 2007-08-28 | The Gillette Company | Reduction of hair growth |
| US6743822B2 (en) | 2001-08-10 | 2004-06-01 | The Gillette Company | Reduction of hair growth |
| US20030036561A1 (en) * | 2001-08-10 | 2003-02-20 | Peter Styczynski | Reduction of hair growth |
| US20040198821A1 (en) * | 2002-01-29 | 2004-10-07 | Hwang Cheng Shine | Reduction of hair growth |
| US7160921B2 (en) * | 2002-01-29 | 2007-01-09 | The Gillette Company | Reduction of hair growth |
| US20030199584A1 (en) * | 2002-04-11 | 2003-10-23 | Ahluwalia Gurpreet S. | Reduction of hair growth |
| US20040141935A1 (en) * | 2003-01-21 | 2004-07-22 | Peter Styczynski | Reduction of hair growth |
| US7015349B2 (en) * | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
| US20050031699A1 (en) | 2003-06-26 | 2005-02-10 | L'oreal | Porous particles loaded with cosmetically or pharmaceutically active compounds |
| US20050249685A1 (en) * | 2004-04-27 | 2005-11-10 | Natalia Botchkareva | Reduction of hair growth |
| EP1765272B1 (en) * | 2004-06-14 | 2009-12-16 | Unilever PLC | Method of decreasing sebum production and pore size |
| US20070032781A1 (en) * | 2004-12-22 | 2007-02-08 | Henry James P | Reduction of hair growth |
| AU2005319166A1 (en) * | 2004-12-22 | 2006-06-29 | The Gillette Company | Reduction of hair growth with survivin inhibitors |
| US20060263438A1 (en) * | 2005-05-17 | 2006-11-23 | L'oreal | Gelled oil particles for targeting sebaceous glands and/or hair follicles |
| US7618956B2 (en) * | 2005-05-31 | 2009-11-17 | The Gillette Company | Reduction of hair growth |
| US20070059264A1 (en) * | 2005-09-13 | 2007-03-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
| US7727516B2 (en) * | 2006-02-28 | 2010-06-01 | The Procter & Gamble Company | Reduction of hair growth |
| US20080206363A1 (en) * | 2007-02-28 | 2008-08-28 | Steve Harlan | Skin stabilizer preparation |
| FR2944443B1 (fr) | 2009-04-21 | 2012-11-09 | Arkema France | Procede de fabrication de particules de poudre libre a base de polyamide impregnee, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique |
| FR2953716B1 (fr) | 2009-12-16 | 2015-03-27 | Oreal | Kit de formulation d'un produit cosmetique |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4161540A (en) * | 1966-08-22 | 1979-07-17 | Schering Corporation | Antiandrogenic agents and methods for the treatment of androgen dependent disease states |
| US4139638A (en) * | 1976-09-23 | 1979-02-13 | Schering Corporation | Methods for the treatment of hirsutism |
| US4207315A (en) * | 1976-10-20 | 1980-06-10 | University Patents, Inc. | Process for treating proliferative skin diseases using certain diamino compounds |
| GB1573036A (en) * | 1977-05-05 | 1980-08-13 | Farmaceutici Italia | Anthracyclines |
| DE2840144A1 (de) * | 1978-09-15 | 1980-03-27 | Goedecke Ag | Topisch applizierbares arzneimittel mit antiandrogener wirkung |
| US4228163A (en) * | 1979-03-30 | 1980-10-14 | Dermik Laboratories | Method for treating pseudofolliculitis barbae |
| DE2943776A1 (de) * | 1979-10-26 | 1981-05-14 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung |
| US4463016A (en) * | 1982-09-22 | 1984-07-31 | Nel's Laboratory, Inc. | Method for the treatment of razor bumps |
| US4525344A (en) * | 1983-08-15 | 1985-06-25 | Tutsky Ronald J | Skin care and shaving composition |
| US4720489A (en) * | 1984-10-15 | 1988-01-19 | Douglas Shander | Hair growth modification with ornithine decarboxylase inhibitors |
| US4786651A (en) * | 1986-02-03 | 1988-11-22 | Allergan, Inc. | Treatment of cutaneous hyperproliferative dermatoses with manoalide |
| US4775530A (en) * | 1987-01-06 | 1988-10-04 | Perricone Nicholas V | Method for treatment and prevention of pseudofolliculitis barbae |
| US4944939A (en) * | 1987-12-14 | 1990-07-31 | Moore Milton D | Shaving preparation for treatment and prevention of PFB (Ingrown Hairs) |
-
1991
- 1991-10-30 US US07/785,032 patent/US5328686A/en not_active Expired - Lifetime
-
1992
- 1992-10-28 DK DK92922984T patent/DK0610368T3/da active
- 1992-10-28 JP JP50851193A patent/JP3534751B2/ja not_active Expired - Fee Related
- 1992-10-28 ZA ZA928345A patent/ZA928345B/xx unknown
- 1992-10-28 HU HU9401258A patent/HU219949B1/hu unknown
- 1992-10-28 UA UA94005502A patent/UA61870C2/uk unknown
- 1992-10-28 ES ES92922984T patent/ES2125276T3/es not_active Expired - Lifetime
- 1992-10-28 AU AU29060/92A patent/AU675918B2/en not_active Expired
- 1992-10-28 KR KR1019940701432A patent/KR100264829B1/ko not_active IP Right Cessation
- 1992-10-28 DE DE69228000T patent/DE69228000T2/de not_active Expired - Lifetime
- 1992-10-28 WO PCT/US1992/009128 patent/WO1993008790A1/en active IP Right Grant
- 1992-10-28 RU RU94022017A patent/RU2130768C1/ru active
- 1992-10-28 AT AT92922984T patent/ATE174785T1/de active
- 1992-10-28 EP EP92922984A patent/EP0610368B1/en not_active Expired - Lifetime
- 1992-10-28 CA CA002121484A patent/CA2121484C/en not_active Expired - Lifetime
-
1994
- 1994-04-29 OA OA60503A patent/OA09920A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA928345B (en) | 1993-05-11 |
| DE69228000T2 (de) | 1999-08-12 |
| KR100264829B1 (ko) | 2000-11-01 |
| OA09920A (en) | 1994-09-15 |
| RU2130768C1 (ru) | 1999-05-27 |
| CA2121484C (en) | 1999-01-19 |
| EP0610368A4 (en) | 1994-12-21 |
| CA2121484A1 (en) | 1993-05-13 |
| JPH07500606A (ja) | 1995-01-19 |
| EP0610368B1 (en) | 1998-12-23 |
| ATE174785T1 (de) | 1999-01-15 |
| DE69228000D1 (de) | 1999-02-04 |
| HU9401258D0 (en) | 1994-08-29 |
| WO1993008790A1 (en) | 1993-05-13 |
| ES2125276T3 (es) | 1999-03-01 |
| EP0610368A1 (en) | 1994-08-17 |
| RU94022017A (ru) | 1996-08-27 |
| MX9206239A (es) | 1998-11-30 |
| AU675918B2 (en) | 1997-02-27 |
| HU219949B1 (en) | 2002-09-28 |
| DK0610368T3 (da) | 1999-08-23 |
| AU2906092A (en) | 1993-06-07 |
| JP3534751B2 (ja) | 2004-06-07 |
| HUT70393A (en) | 1995-10-30 |
| US5328686A (en) | 1994-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA61870C2 (en) | Method for treating acne and pseudofolliculitis barbae, methods for producing compositions, composition for treating acne | |
| US3729568A (en) | Acne treatment | |
| ATE214933T1 (de) | Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten | |
| JP2007302680A (ja) | 酸性プロテアーゼ酵素と酸性緩衝剤の組合せおよびその使用 | |
| EP0863740A1 (en) | Reduction of hair growth | |
| NZ223558A (en) | Acne treatment composition | |
| JP2010502700A (ja) | アクネを治療する医薬品、加齢および日焼けの症状を回復する医薬品、及び、これを用いた方法 | |
| Lassus et al. | A dimethoxynaphthalene derivative (RS‐43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis | |
| Olsen | Therapy of acne | |
| US5667790A (en) | Aluminum chlorhydrate as a treatment for acne and rosacea | |
| MXPA03007151A (es) | Curacion de acrocordones. | |
| Zachariae | Dermabrasion in Darier's disease | |
| Griffiths | Pityriasis rubra pilaris | |
| DK165938B (da) | Topisk middel til behandling af non-inflammatorisk acne | |
| Bachynsky et al. | Dissecting folliculitis of the scalp: A case report of combined treatment using tissue expansion, radical excision, and isotretinoin | |
| JPH11100324A (ja) | ニキビ治療用組成物 | |
| EP0086228B1 (en) | Use of carbamide peroxide for the manufacture of a medicament for treatment of acne vulgaris | |
| Christiansen et al. | Etretinate (Tigason®) and Betamethasone Valerate (Celeston Valerate®) in the Treatment of Psoriasis: A Double-Blind, Randomized, Multicenter Trial | |
| Grimes | Salicylic acid peels | |
| HU211255A9 (en) | Synergistic skin depigmentation composition | |
| JP2017534689A (ja) | ざ瘡の予防および治療のための方法 | |
| Shalita | Topical acne therapy | |
| JPH09509933A (ja) | 抗アクネ組成物 | |
| US11458114B2 (en) | Methods and compositions for enhancing synthesis secretion and transport of collagen to increase wound strength | |
| MXPA92006239A (en) | Treatment of acne or of pseudo folliculitis barbae |